Mohamed Genead
Chief Executive Officer at Aviceda Therapeutics, Inc.
Mohamed Genead active positions
| Companies | Position | Start | End |
|---|---|---|---|
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Founder | - | - | |
| President | - | - | |
| Corporate Secretary | - | - | |
| Treasurer | - | - | |
Aviceda Ophthalmics, Inc.
 Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Chief Executive Officer | - | - |
| Chairman | - | - | |
| Director of Finance/CFO | - | - | |
| President | - | - | |
| Corporate Secretary | - | - |
Career history of Mohamed Genead
Former positions of Mohamed Genead
| Companies | Position | Start | End |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Chief Tech/Sci/R&D Officer | 2017-04-30 | 2017-10-31 |
| University of Illinois | Corporate Officer/Principal | - | - |
| OCUGEN, INC. | Chief Tech/Sci/R&D Officer | - | - |
Statistics
International
| United States | 5 |
| France | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
- Stock Market
- Insiders
- Mohamed Genead
- Experience
